Monitor for imminent pricing and offering details, which could lead to significant share dilution given the company's small market cap. The effectiveness of two S-1s simultaneously suggests a material capital raise is likely imminent.
Price Chart
Executive Summary
GeoVax Labs, Inc. has two S-1 registration statements (Nos. 333-295081 and 333-295082) that became effective on April 21, 2026, enabling the company to proceed with public offerings of its securities. This follows a prior S-1 filing from December 12, 2025, indicating ongoing capital-raising efforts.
Key Facts
- Two EFFECT filings for S-1 registration statements (Nos. 333-295081 and 333-295082) became effective on April 21, 2026.
- The underlying S-1 was originally filed on December 12, 2025, indicating a completed SEC review process.
- Effectiveness allows GeoVax to legally offer and sell securities to the public, though exact terms (pricing, size) are not disclosed in this filing.
- Company is in the pharmaceutical preclinical stage with a $3M market cap, suggesting high risk and potential volatility from dilution.
Financial Impact
Potential for near-term capital raising through public offering; exact size and dilution impact not specified.
Risk Factors
- Significant shareholder dilution upon issuance of new shares.
- Downward pressure on stock price due to oversupply in a low-liquidity microcap stock.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (GOVX) — Batch item 1 | 9999999995-26-001278 |
| Document: 9999999995-26-001278-index.html | 9999999995-26-001277 |
| Document: 9999999995-26-001278.txt | 9999999995-26-001278 |
| EFFECT Filing (GOVX) — Batch item 4 | 9999999995-26-001277 |
| Document: 9999999995-26-001277-index.html | 9999999995-26-001278 |
| Document: 9999999995-26-001277.txt | 9999999995-26-001278 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | 8-K | $0.2032 | awaiting T+60 | — | $0.2010 (+1.08%) |
Sep 24, 2026 4w ago | EFFECT | $0.3603 | awaiting T+60 | — | $0.2010 (+44.21%) |
Jun 4, 2026 20w ago | EFFECT | $1.79 $0.7210 | ▲ +59.72% | ▲ +61.60% | $0.2010 (+88.77%) |
May 26, 2026 22w ago | S-1 | $3.49 $0.5947 | ▼ −82.96% | ▼ −85.68% | $0.2010 (−94.24%) |
May 19, 2026 23w ago | 8-K | $2.23 $0.7180 | ▲ +67.80% | ▲ +72.81% | $0.2010 (+90.99%) |
May 14, 2026 23w ago | 8-K | $1.23 $0.7700 | ▲ +37.40% | ▲ +41.91% | $0.2010 (+83.66%) |
May 7, 2026 24w ago | 8-K | $1.67 $0.7620 | ▲ +54.37% | ▲ +59.21% | $0.2010 (+87.96%) |
Apr 22, 2026 27w ago | EFFECT | $1.17 $0.9742 | ▼ −16.73% | ▼ −21.51% | $0.2010 (−82.82%) |
Apr 20, 2026 27w ago | EFFECT | $1.17 $1.01 | ▲ +13.68% | ▲ +20.45% | $0.2010 (+82.82%) |
Apr 15, 2026 27w ago | 8-K | $1.23 $1.11 | ▲ +9.76% | ▲ +16.80% | $0.2010 (+83.66%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers